2024

1. A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels

   Clinical Gastroenterology and Hepatology

2. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

   Scientific reports, Vol. 14, Núm. 1, pp. 3000

3. Author response to: Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST)

   British Journal of Surgery

4. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

   Gastric Cancer

5. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

   Therapeutic Advances in Gastroenterology, Vol. 17

6. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer

   Colorectal Disease

7. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer

   Colorectal Disease, Vol. 26, Núm. 5, pp. 926-931

8. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

   Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

9. Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

   American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 646-654

10. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, pp. 257-264

11. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma

    Gastroenterology, Vol. 166, Núm. 5, pp. 886-901.e7

12. Fragility Index, Reverse Fragility Index, Fragility Quotients, and Susceptibility Index. Novel tools for assessing of randomized clinical trials

    Cirugia Espanola, Vol. 102, Núm. 1, pp. 41-43

13. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma

    Hepatology, Vol. 79, Núm. 4, pp. 941-958

14. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes

    Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359

15. Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 4, pp. 578-588

16. Non-specific protection against severe COVID-19 associated to typhoid fever and DTP vaccination

    Heliyon, Vol. 10, Núm. 9

17. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management

    United European Gastroenterology Journal, Vol. 12, Núm. 1, pp. 122-138

18. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola

19. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

    Pharmaceutics, Vol. 16, Núm. 5

20. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318